Table 1 Relationship between the subcellular distribution of p57 protein and clinicopathologic factors in cancerous tissues of hepatocellular carcinoma patients
From: The role of cytoplasmic p57 in invasion of hepatocellular carcinoma
Variable | n | Nuclear p57 (\( \overline{x} \) ± s) | P | Cytoplasmic p57 (\( \overline{x} \) ± s) | P |
|---|---|---|---|---|---|
Tumor size | 0.016* | 0.199 | |||
<50 mm | 18 | 4.82 ± 3.10 | 4.32 ± 2.92 | ||
≥50 mm | 27 | 2.88 ± 2.65 | 3.18 ± 3.33 | ||
Histological grade | 0.283 | 0.503 | |||
I + II | 36 | 3.88 ± 3.08 | 3.79 ± 3.17 | ||
III | 9 | 2.83 ± 2.48 | 3.08 ± 3.37 | ||
TNM stage | 0.150 | 0.098 | |||
I + II | 12 | 4.60 ± 3.07 | 4.80 ± 3.57 | ||
III + IV | 33 | 3.30 ± 2.89 | 3.20 ± 2.97 | ||
Capsular invasion and extrahepatic metastasis | 0.05 | 0.013 | |||
Positive | 24 | 2.97 ± 2.86 | 2.71 ± 3.10 | ||
Negative | 21 | 4.54 ± 2.93 | 4.83 ± 2.96 | ||
AFP | 0.131 | 0.670 | |||
<400 μg · L−1 | 21 | 4.32 ± 2.84 | 3.84 ± 3.13 | ||
≥400 μg · L−1 | 24 | 3.10 ± 3.01 | 3.47 ± 3.29 | ||